The FDA has accepted the New Drug Application for doravirine/islatravir for adults with virologically-suppressed HIV-1 infection.

The U.S. Food and Drug Administration's reviewers on Wednesday raised efficacy concerns over the use of Otsuka Pharma's drug in combination with Viatris' Zoloft for the treatment of adults with PTSD.

The Food and Drug Administration (FDA) has accepted for review Milestone’s response to issues raised in a Complete Response Letter (CRL) for etripamil nasal spray (Cardamyst ™ ), an investigational ...

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the “Company”), and a clinical stage, leading global ...

The uncertainty around tariffs and trade production measures has muted economic growth. President Trump has once again ...

US FDA approves Bayer’s finerenone for new indication in patients with heart failure with left ventricular ejection fraction of ≥ 40%: Berlin Wednesday, July 16, 2025, 13:00 H ...

Traditional medicine is a centuries-old practice and belief system across cultures that typically takes a holistic approach ...

Scale AI, a private U.S. artificial intelligence company, laid off 14% of staff after tech giant Meta took a $14.3 billion ...

Amazon.com Inc.’s carbon emissions rose for the first time in three years in 2024, driven by data center construction and ...

Experts discuss how academic publishing must change to support open science, transparency and global accessibility in a ...

Bengaluru: Bengaluru-based QpiAI, which provides integrated AI and quantum solutions for enterprises, raised $32 million led by Avataar Ventures and t.

Eight healthy babies were born in Britain with the help of an experimental technique that uses DNA from three people to help ...